Sustainability & Climate

Private equity giant EQT sells its final stake in Azelis, marking a highly successful investment and leaving the chemicals firm to chart its own course.

Electric outboard maker Flux Marine hires Mercury Marine's former strategy head, signaling a push from niche tech to mainstream market dominance.

The electronic components supplier reports a 16.4% sales jump, expands into Europe, and targets the booming AI market while de-risking its supply chain.

The SW Graduate School of Banking will honor TIB's Michael O'Rourke and Tolleson Wealth Management's J. Carter Tolleson for their industry leadership.

Minsud Resources and partner South32 report a massive resource increase, positioning the Chita Valley project as a potential district-scale copper giant.

With a massive $1.7B war chest from government and industry, can Japan's Rapidus truly race against TSMC and Samsung to mass-produce 2nm chips by 2027?

As processed foods dominate diets, a 97-year-old company doubles down on its farm-to-supplement model, banking on science and soil to change lives.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

How did a young appliance brand disrupt the juicer market? Canoly's C16 success reveals a powerful blend of smart tech and the booming at-home wellness trend.

Asia's top woodworking expo kicks off in Bengaluru, showcasing cutting-edge tech and solidifying India's role as a global furniture production powerhouse.

With U.S. cancer centers tripling adoption of its targeted drug delivery device, RenovoRx signals a potential shift in treating solid tumors.

Yosemite drops its reservation system for real-time traffic tech, online tickets, and new Wi-Fi, promising smoother access but raising crowding concerns.

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

Artera secures the top spot in the 2026 Best in KLAS awards, a win validating its AI-driven approach to revolutionizing patient communication.

A new emergency epilepsy medication for children is now available, offering a faster, easier-to-use option for caregivers to stop prolonged seizures.

A new partnership aims to end pharmacy sticker shock by giving patients unprecedented control over prescription price, location, and availability.

Childhelp co-founder Sara O'Meara receives a lifetime achievement award, highlighting a new partnership and the ongoing fight to protect vulnerable children.

After securing its Nasdaq spot, TuHURA Biosciences shifts focus to its promising immuno-oncology pipeline, aiming to tackle cancer treatment resistance.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.